The Anti-CD3-Induced Syndrome: A Consequence of Massive In Vivo Cell Activation (original) (raw)

• Abramowicz D, Schandenne L, Goldman M, Crusiaux A, Vereerstraeten P, de Pauw L, Wybran J, Kinnaert P, Dupont E, Toussaint C (1989) Release of tumor necrosis factor, interleukin 2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47: 606–613
  Article PubMed CAS Google Scholar
• Aggarwal BB, Eessalu TE, Hass PE (1985) Characterization of receptors for human tumor necrosis factor and their regulation by γ interferon. Nature 318: 665–667
  Article PubMed CAS Google Scholar
• Apte RN, Pluznik DH (1976) Genetic control of lipopolysaccharide induced generation of serum colony stimulating factor and proliferation of splenic granulocyte/macrophage precursor cells. J Cell Physiol 89: 313–323
  Article PubMed CAS Google Scholar
• Alegre M, Vandenabeele P, Flamand V, Moser M, Leo O, Abramowicz D, Urbain J, Fiers W, Goldman M (1990) Hypothemia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice; role of tumor necrosis factor. Eur J Immunol 20: 707–710
  Article PubMed CAS Google Scholar
• Arya SK, Wong-Staal F, Gallo RC (1984) Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 133: 273–276
  PubMed CAS Google Scholar
• Barnett-Sultzer (1968) Genetic control of leucocyte responses to endotoxin. Nature 219: 1253–1254
  Article Google Scholar
• Benjamin RJ, Cobbod SP, Clark MR, Waldmann H (1986) Tolerance to rat monoclonal antibodies. J Exp Med 163: 1539–1552
  Article PubMed CAS Google Scholar
• Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986a) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977–980
  Article PubMed CAS Google Scholar
• Beutler B, Tkacenko V, Milsark I, Krochin N, Cerami A (1986b) Effect of γ interferon on cachectin expression by mononuclear phagocytes. Reversal of the (Ips d) (endoxin resistance) phenotype. J Exp Med 164: 1791–1796
  Article PubMed CAS Google Scholar
• Borst J, Alexander S, Elder J, Terhorst C (1983) The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem 258: 5135–5141
  PubMed CAS Google Scholar
• Borst J, Colligan JE, Oettgen H, Pessano S, Malin R, Terhorst C (1984) The gamma and epsilon chains of the human T3/T cell receptor complex are distinct polypeptides. Nature 312: 455–458
  Article PubMed CAS Google Scholar
• Chang TW, Kung PC, Gingras SP, Goldstein G (1981) Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells? Proc Natl Acad Sci USA 78: 1805–1808
  Article PubMed CAS Google Scholar
• Chatenoud L, Bach JF (1984) Antigenic modulation. A major mechanism of antibody action. Immunol Today 5: 20–25
  Article CAS Google Scholar
• Chatenoud L, Ferran C, Reuter A, Franchimont P, Legendre C, Kreis H, Bach JF (1988) Clinical use of OKT3:the role of cytokine release and xenosensitization. J Autoimmun 1: 631–639
  Article Google Scholar
• Chatenoud L, Ferran C, Reuter A, Legendre C, Gevaert Y, Kreis H, Franchimont P, Bach JF (1989) Systemic reaction to the monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon γ. N Engl J Med 320: 1420–1421
  Article PubMed CAS Google Scholar
• Chatenoud L, Ferran C, Legendre C, Thouard I, Merite S, Reuter A, Gevaert Y, Kreis H, Franchimont P, Bach JF (1990) In vivo cell activation following OKT3 administration; systemic cytokine release and modulation by corticosteroids. Transplantation 49: 697–702
  Article PubMed CAS Google Scholar
• Chatenoud L, Legendre C, Ferran C, Bach JF, Kreis H (1991) Corticosteroids inhibition of the OKT3 induced cytokine related syndrome-dosage and kinetics prerequisites. Transplantation 51 (in press)
  Google Scholar
• Clevers H, Alarcon B, Wileman T, Terhorst C (1988) The T cell receptor/CD3 complex: dynamic protein ensemble. Annu Rev Immunol 6: 629–662
  Article PubMed CAS Google Scholar
• Cosimi AB (1987) Clinical development of orthoclone OKT3. Transplant Proc [Suppl 1] 14: 7–16
  Google Scholar
• Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen P, Delmonico FL, Russel PS (1981) Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med 305: 308–314
  Article PubMed CAS Google Scholar
• Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G (1987) Independant regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 165: 1581–1584
  Article PubMed CAS Google Scholar
• Ellenhorn JDI, Woodle ES, Ghobreal I, Thistlethwaite JR, Bluestone J (1990) Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation 50: 608–612
  Article PubMed CAS Google Scholar
• Ferran C, Sheehan C, Dy M, Schreiber R, Merite S, Landais P, Noel LH, Grau G, Bluestone J, Bach JF, Chatenoud L (1990a) Cytokine related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol 20: 509–515
  Article PubMed CAS Google Scholar
• Ferran C, Dy M, Merite S, Sheehan K, Schreiber R, Leboulenger F, Landais P, Bluestone JA, Bach JF, Chatenoud L (1990b) Corticosteroids reduce morbidity and cytokine release in anti-CD3 MoAb treated mice. Transplantation 50: 642–648
  Article PubMed CAS Google Scholar
• Ferran C, Sheehan K, Schreiber R, Bach JF, Chatenoud L (1991) Anti-TNF abrogates the cytokine related anti-CD3 induced syndrome. Transplant Proc 23(1): 849–850
  PubMed CAS Google Scholar
• Goldstein G, Norman DJ, Shield CF, Kreis H, Burdick J (1986) OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments. In: (Meryman HT (ed)) Transplantation: approaches to graft rejection. Liss, New York, pp 239–249
  Google Scholar
• Grau G, Frei K, Piguet PF, Fontana A, Heremans H, Billiau A, Vassalli P, Lambert PH (1990) Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role of hypergammaglobulinemia. J Exp Med 172: 1505–1508
  Article PubMed CAS Google Scholar
• Hafler DA, Ritz J, Schlossmann SF, Weiner HL (1988) Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effect and anti-mouse immune response. J Immunol 141: 131–138
  PubMed CAS Google Scholar
• Heinzel FP, Sadick MP, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J Exp Med 169: 59–72
  Article PubMed CAS Google Scholar
• Hirsch R, Eckhaus M, Auchincloss H Jr, Sachs DH, Bluestone JA (1988) Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J Immunol 140: 3766–3772
  PubMed CAS Google Scholar
• Hirsch R, Gress RE, Pluznik DH, Eckhaus M, Bluestone JA (1989) Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J Immunol 142: 737–743
  PubMed CAS Google Scholar
• Hirsch R, Bluestone JA, DeNenno L, Gress RE (1990) Anti-CD3 F(ab’)2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 49: 1117–1123
  Article PubMed CAS Google Scholar
• Jacob CO, McDevitt HO (1988) Tumour necrosis factor-α in murine autoimmune “lupus” nephritis. Nature 331: 356–358
  Article PubMed CAS Google Scholar
• Jonker M, Goldstein G, Balner H (1983) Effects of in vivo administration of monoclonal antibodies specific for human T cell subpopulations on the immune system in a Rhesus monkey model. Transplantation 35: 521–526
  Article PubMed CAS Google Scholar
• Kindler V, Sappino AP, Grau GE, Piguet PF, Vassali P (1989) The inducing role of tumor necrosis factor irr the development of bactericidal granulomas during BCG infection. Cell 56: 731–740
  Article PubMed CAS Google Scholar
• Kung PC, Goldstein G, Reinherz E, Schlossman SF (1979) Monoclonal antibodies defining distinctive human T-cell surface antigens. Science 206: 347–349
  Article PubMed CAS Google Scholar
• Lee SW, Tsou AP, Chan H (1988) Dexamethasone mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. Proc Natl Acad Sci USA 85: 1204–1208
  Article PubMed CAS Google Scholar
• Leo O, Foo M, Sachs DH, Samelson LE, Buestone SA (1987) Identification of a monoclonal antibody specific for a marine T3 polypeptide. Proc Natl Acad Sci (USA) 84: 1374–1377
  Article CAS Google Scholar
• Martin MA, Massanari RM, Nghiem DD, Smith JL, Corry RJ (1988) Nosocomial aseptic meningitis associated with administration of OKT3. JAMA 259: 2002–2005
  Article PubMed CAS Google Scholar
• Meuer SC, Fitzgerald KA, Hussey RE, Hodgdon JC, Schlossman SF, Reinherz EL (1983) Clonotypic structures involved in antigen specific human T cell function. Relationship to the T3 molecular complex. J Exp Med 157: 705–719
  Article PubMed CAS Google Scholar
• Michie HR, Manogue KR, Sprigs DR, Revhaug A, O’Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318: 1481–1486
  Article PubMed CAS Google Scholar
• Oettgen H, Kappler J, Tax WJM, Terhorst C (1984) Characterization of the two heavy chains of the T3 complex on the surface of human T lymphocytes. J Biol Chem 259: 12039–12048
  PubMed CAS Google Scholar
• Ortho Multicenter Transplant Study Group (1985) A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. N Engl J Med 313: 337–342
  Article Google Scholar
• Pessano S, Oettgen H, Bhan AK, Terhorst C (1985) The T3/T cell receptor complex: antigenic distinction between the 20 kDa T3 (T3-δ and T3-δ) subunits. EMBO J 4: 337–344
  PubMed CAS Google Scholar
• Philip R, Epstein LB (1986) Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ interferon and interleukin-1. Nature 323: 86–89
  Article PubMed CAS Google Scholar
• Piguet PF, Grau G, Collart MA, Vassalli P, Kapanci Y (1989) Pneumopathies of the graft versus host reaction. Lab Invest 61: 37–45
  PubMed CAS Google Scholar
• Piguet PF, Collart MA, Grau G, Sappino AP, Vassalli P (1990) Requirement of tumor necrosis factor for development of the silica-induced pulmonary fibrosis. Nature 344: 245–247
  Article PubMed CAS Google Scholar
• Reed JC, Abidi AH, Alpers JD, Hoover RG, Robb RJ, Nowell PC (1986) Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J Immunol 137: 150–154
  PubMed CAS Google Scholar
• Remick DG, Kungel RG, Larrick JW, Kunkel SL (1987) Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 56: 583–590
  PubMed CAS Google Scholar
• Richards JM, Vogelzang NJ, Bluestone JA (1990) Neurotoxicity after treatment with muromonab-CD3. N Engl J Med 323: 487
  Article PubMed CAS Google Scholar
• Rosenberg SA, Lotze MT, Mutt LM, Chang AE, Avis FP, Leitman S, Linehan N, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 316: 889–897
  Article PubMed CAS Google Scholar
• Samelson LE, Harford JB, Klausner RD (1985) Identification of the components of the murine T cell antigen receptor complex. Cell 43: 223–231
  Article PubMed CAS Google Scholar
• Schreiber RD, Hicks LJ, Celada A, Buchmeier NA, Gray PW (1985) Monoclonal antibodies to murine γ-interferon which differentially modulate macrophage activation and anti-viral activity. J Immunol 134: 1609–1618
  PubMed CAS Google Scholar
• Sheehan KCF, Ruddle NH, Schreiber RD (1989) Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 142: 3884–3893
  PubMed CAS Google Scholar
• Skidmore BJ, Chiller JC, Morrison DC, Weigle WO (1975) Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. J Immunol 114: 770–778
  PubMed CAS Google Scholar
• Sultzer BM (1968) Genetic control of leucocyte response to endotoxin. Nature 219: 1253–1254
  Article PubMed CAS Google Scholar
• Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard HM, Liggitt D (1987) Toxicity of tumor necrosis factor is synergistic with γ interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol 128: 410–425
  PubMed CAS Google Scholar
• Tsujimoto M, Yip YK, Vilcek J (1986) Interferon γ enhances expression of cellular receptors for tumor necrosis factor. J Immunol 136: 2441–2450
  PubMed CAS Google Scholar
• Van Lier RAW, Boot JHA, de Groot ER, Aarden LA (1987) Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies; effects of heavy chain isotype in monocyte dependent systems. Eur J Immunol 17:1599–1604
  Article PubMed Google Scholar
• Van Wauwe JP, de May JR, Goossens JG (1980) OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol 124: 2708–2713
  PubMed Google Scholar
• Watson J, Largen M, McAdam KPWJ (1978) Genetic control of endotoxin responses in mice. J Exp Med 147: 39–49
  Article PubMed CAS Google Scholar
• Wofsy D, Seaman WE (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161: 378–391
  Article PubMed CAS Google Scholar
• Zuckerman SH, Shellhaas J, Butler LD (1989) Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19: 301–305
  Article PubMed CAS Google Scholar